Clinical trial BT5528-100
Phase I/II Study of the Safety, Pharmacokinetics, and Preliminary Clinical Activity of BT5528 in Patients with Advanced Malignancies Associated with EphA2 Expression
| Organ | Multiple |
|---|---|
| Trial status | Trial open for recruitment |
| Investigator | |
| Trial type |
Interventional with experimental drug
|
| Phase | Trial phase 1/2 |
| Academic trial | Non |
| Sponsor | Bicycle Tx Limited |
| EudraCT Identifier | 2019-003653-29 |
| ClinicalTrials.gov | https://clinicaltrials.gov/ct2/show/NCT04180371 |
| Last update |